company background image
HOLX

Hologic NasdaqGS:HOLX Stock Report

Last Price

US$84.68

Market Cap

US$20.9b

7D

2.3%

1Y

13.3%

Updated

05 Feb, 2023

Data

Company Financials +

HOLX Stock Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally.

HOLX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Hologic, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hologic
Historical stock prices
Current Share PriceUS$84.68
52 Week HighUS$85.31
52 Week LowUS$59.78
Beta1.02
1 Month Change8.80%
3 Month Change13.89%
1 Year Change13.30%
3 Year Change59.26%
5 Year Change124.32%
Change since IPO3,442.17%

Recent News & Updates

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Recent updates

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?

Jan 03
Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?

Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns

Dec 02
Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Oct 12
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Sep 27
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Hologic announces $1B share buyback program

Sep 26

We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending

Aug 27
We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending

Hologic cut to Neutral at BTIG on macro concerns

Jul 18

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 11
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Jun 28
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 41%?

Jun 15
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 41%?

Hologic: Unfairly Punished, Or Not? Examination Of Cash Flow And Earnings

Jun 03

Returns on Capital Paint A Bright Future For Hologic (NASDAQ:HOLX)

May 09
Returns on Capital Paint A Bright Future For Hologic (NASDAQ:HOLX)

Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Apr 12
Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Is It Time To Consider Buying Hologic, Inc. (NASDAQ:HOLX)?

Mar 30
Is It Time To Consider Buying Hologic, Inc. (NASDAQ:HOLX)?

A Look At The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Mar 17
A Look At The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

We Think Hologic, Inc.'s (NASDAQ:HOLX) CEO Compensation Looks Fair

Mar 04
We Think Hologic, Inc.'s (NASDAQ:HOLX) CEO Compensation Looks Fair

Hologic's Underperformance Makes This A Name Worth Further Consideration

Feb 17

Is Hologic (NASDAQ:HOLX) A Risky Investment?

Jan 02
Is Hologic (NASDAQ:HOLX) A Risky Investment?

What Is Hologic, Inc.'s (NASDAQ:HOLX) Share Price Doing?

Dec 20
What Is Hologic, Inc.'s (NASDAQ:HOLX) Share Price Doing?

Is There An Opportunity With Hologic, Inc.'s (NASDAQ:HOLX) 29% Undervaluation?

Dec 07
Is There An Opportunity With Hologic, Inc.'s (NASDAQ:HOLX) 29% Undervaluation?

Hologic: Still Going Strong

Nov 28

If You Like EPS Growth Then Check Out Hologic (NASDAQ:HOLX) Before It's Too Late

Oct 20
If You Like EPS Growth Then Check Out Hologic (NASDAQ:HOLX) Before It's Too Late

Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Sep 23
Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Hologic: An Undervalued Leader

Sep 23

Is Now An Opportune Moment To Examine Hologic, Inc. (NASDAQ:HOLX)?

Sep 10
Is Now An Opportune Moment To Examine Hologic, Inc. (NASDAQ:HOLX)?

Is There An Opportunity With Hologic, Inc.'s (NASDAQ:HOLX) 25% Undervaluation?

Aug 26
Is There An Opportunity With Hologic, Inc.'s (NASDAQ:HOLX) 25% Undervaluation?

Hologic: Prepare For Takeoff

Jul 29

Do Hologic's (NASDAQ:HOLX) Earnings Warrant Your Attention?

Jul 18
Do Hologic's (NASDAQ:HOLX) Earnings Warrant Your Attention?

Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Jun 21
Is Hologic (NASDAQ:HOLX) Using Too Much Debt?

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Jun 08
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Estimating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

May 26
Estimating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic falls on Q2 earnings miss and worse-than-expected guidance

Apr 28

Hologic (NASDAQ:HOLX) Could Easily Take On More Debt

Mar 14
Hologic (NASDAQ:HOLX) Could Easily Take On More Debt

Shareholder Returns

HOLXUS Medical EquipmentUS Market
7D2.3%3.8%1.7%
1Y13.3%-9.3%-9.6%

Return vs Industry: HOLX exceeded the US Medical Equipment industry which returned -9.3% over the past year.

Return vs Market: HOLX exceeded the US Market which returned -9.6% over the past year.

Price Volatility

Is HOLX's price volatile compared to industry and market?
HOLX volatility
HOLX Average Weekly Movement3.0%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: HOLX is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: HOLX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19856,944Steve MacMillanhttps://www.hologic.com

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
HOLX fundamental statistics
Market CapUS$20.88b
Earnings (TTM)US$990.20m
Revenue (TTM)US$4.47b

21.1x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HOLX income statement (TTM)
RevenueUS$4.47b
Cost of RevenueUS$1.54b
Gross ProfitUS$2.92b
Other ExpensesUS$1.93b
EarningsUS$990.20m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)4.02
Gross Margin65.45%
Net Profit Margin22.17%
Debt/Equity Ratio55.5%

How did HOLX perform over the long term?

See historical performance and comparison